SR ONE CAPITAL MANAGEMENT, LP - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SR ONE CAPITAL MANAGEMENT, LP ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,025,047
-28.0%
6,822,1140.0%2.06%
-14.5%
Q2 2023$5,594,133
+134.3%
6,822,1140.0%2.41%
+171.3%
Q1 2023$2,387,740
-18.6%
6,822,1140.0%0.89%
-17.0%
Q4 2022$2,933,509
-24.6%
6,822,1140.0%1.07%
-39.8%
Q3 2022$3,889,000
-59.9%
6,822,1140.0%1.78%
-62.5%
Q2 2022$9,687,000
-64.6%
6,822,1140.0%4.74%
-66.1%
Q1 2022$27,357,000
-51.6%
6,822,1140.0%14.00%
-56.1%
Q4 2021$56,487,0006,822,11431.92%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$3,889,0001.78%
Abingworth LLP 4,822,114$2,730,0000.93%
OUP Management Co., LLC 1,025,697$587,0000.91%
Column Group LLC 4,309,329$2,465,0000.55%
Evolution Capital Management LLC 527,885$302,0000.44%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,363,0000.27%
Parallel Advisors, LLC 1,693,559$969,0000.04%
RESOLUTE FINANCIAL, LLC 31,000$18,0000.02%
Oasis Management Co Ltd. 100,000$57,0000.01%
Wescott Financial Advisory Group, LLC 55,556$32,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders